Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/1078155220988753 http://scihub22266oqcxt.onion/10.1177/1078155220988753 33470163!ä!33470163 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Oncol+Pharm+Pract 2021 ; 27 (2): 450-452 Nephropedia Template TP {{tp|p=33470163|t=2021. Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle?|pdf=|usr=}}{{33470163}} gab.com Text Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle JO: J Oncol Pharm Pract http://www.kidney.de/pget.php?&tw=1&pmid=33470163 #FOAvip Cancer patients under active chemotherapy are more vulnerable to coronavirus disease 19 (COVID-19). There are still some controversies regarding routine polymerase chain reaction testing of asymptomatic cancer patients before chemotherapy cycles. Despite a lack of data, Al-Shamsi et al. showed higher COVID-19 positivity rate among asymptomatic cancer patients. Furthermore, mortality rate was higher in this group of patients. There is no high evidence-based recommendation from the cancer societies for testing asymptomatic patients before each chemotherapy cycle. In this commentary, we assessed the current publications and guidelines regarding this issue. Twit Text FOAVip Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle ????J Oncol Pharm Pract http://www.kidney.de/pget.php?&tw=1&pmid=33470163 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33470163 #FOAvip English Wikipedia <ref>{{Cite pmid|33470163}}</ref> Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle? #MMPMID33470163 Yekeduz E; Utkan G; Urun Y J Oncol Pharm Pract 2021[Mar]; 27 (2): 450-452 PMID33470163show ga Cancer patients under active chemotherapy are more vulnerable to coronavirus disease 19 (COVID-19). There are still some controversies regarding routine polymerase chain reaction testing of asymptomatic cancer patients before chemotherapy cycles. Despite a lack of data, Al-Shamsi et al. showed higher COVID-19 positivity rate among asymptomatic cancer patients. Furthermore, mortality rate was higher in this group of patients. There is no high evidence-based recommendation from the cancer societies for testing asymptomatic patients before each chemotherapy cycle. In this commentary, we assessed the current publications and guidelines regarding this issue. |*COVID-19 Testing[MESH] |Antineoplastic Agents/*therapeutic use[MESH] |COVID-19/complications[MESH] |Evidence-Based Medicine[MESH] |Guidelines as Topic[MESH] |Humans[MESH]Commentary: Should all cancer patients be tested for COVID-19 before e(epmc).pdf DeepDyve Pubget Overpricing